Special Issue

Topic: Papers from the Meeting of the European Organization of Research and Treatment of Cancer (EORTC) - Pharmacology and Molecular Mechanisms (PAMM) Group

A Special Issue of Cancer Drug Resistance

ISSN 2578-532X (Online)

Submission deadline: 31 Aug 2024

Guest Editor(s)

Dr. Godefridus J. (Frits) Peters

Amsterdam UMC, location VUMC, Laboratory Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands.

Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland.

Dr. Elisa Giovannetti

Lab Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.

Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa, Italy.

Dr. Joseph Ciccolini

Laboratoire de Pharmacocinétique et Toxicologie, CHU Timone, APHM, Marseille, France.

SMARTc unit, Centre de Recherche en Cancérologie de Marseille, Marseille, France.

Special Issue Introduction

Cancer Drug Resistance is cooperating with the Meeting of the European Organization of Research and Treatment of Cancer (EORTC) - Pharmacology and Molecular Mechanisms (PAMM) Group (https://www.pamm-meeting.com/) and launching a Special Conference Issue. The 44th Meeting of EORTC - PAMM Group will be held on February 7th to 10th, 2024 in Marseille, France. The PAMM EORTC meeting is a unique blend of translational and clinical research in oncology - covering the latest innovations in targeted therapies and immunotherapies, experimental therapeutics, precision medicine and cutting-edge oncology. The Special Issue will focus on a selection of papers from the conference to cover advances in cancer drug resistance.

Keywords

Cancer drug discovery, mechanisms of action of novel drugs, drug resistance

Submission Deadline

31 Aug 2024

Submission Information

For Author Instructions, please refer to https://www.oaepublish.com/cdr/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=cdr&SpecialIssueId=CDR221103
Submission Deadline: 31 Aug 2024

Contacts: Susan Song, Managing Editor, susan@cdrjournal.com

Published Articles

Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cells

Open Access Original Article DOI: 10.20517/cdr.2023.20 3 Jul 2023
Views: Downloads:
Download PDF
Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/